February 27th, 2026 - Dr. Tahmid Rahman

Dr. Tahmid Rahman, co-director of the Center for Advanced Lipid Management at the Stony Brook Heart Institute, joins Heart of The East End Gianna Volpe on WLIW-FM to talk about the heart institute being the first center in the world to administer a commercial dose of plozasiran, the newly approved RNA-interference therapy for Familial Chylomicronemia Syndrome marked by extreme triglyceride levels—often 10 to 100 times above normal—leading to recurrent and severe pancreatitis.Listen to the playlist on Apple Music